Curable composition
AssigneeSunstar Engineering Inc.
InventorsTakuro Omachi, Akimi Ebata, Hiroyuki Nagata
Life of this patent
Estimating the term…
Abstract
A curable composition used to produce a polyurethane foam comprises an isocyanate group-containing urethane pre-polymer (I) having an oxyalkylene ether skeleton and no siloxane skeleton, and an isocyanate group-containing urethane pre-polymer (II) having a siloxane skeleton and an oxyalkylene ether skeleton.
Claims15
A polyurethane foam produced from a curable composition comprising:
- an isocyanate group-containing urethane pre-polymer (I) that has an oxyalkylene ether skeleton and no siloxane skeleton;
- and
- an isocyanate group-containing urethane pre-polymer (II) that has a siloxane skeleton and an oxyalkylene ether skeleton, wherein
- the siloxane skeleton is represented by the following formula (1);
- and wherein
- Ra and Rb each independently represent a monovalent substituent group and r represents an integer equal to or larger than 1,
- wherein the foam is a closed-cell foam, and the cells have a mode average diameter <150 μm.
A polyurethane foam produced from a curable composition comprising:
- an isocyanate group-containing urethane pre-polymer (I) that has an oxyalkylene ether skeleton and no siloxane skeleton;
- and
- an isocyanate group-containing urethane pre-polymer (II) that has a siloxane skeleton and an oxyalkylene ether skeleton, represented by the following formula (2),
- wherein each R1 is independently a monovalent hydrocarbon group, each R2 is independently a straight-chain or a branched-chain alkylene group having 1 to 6 carbon atoms, each R3 is independently an oxyalkylene group represented by a formula —[R6—O]m—, wherein R6 represents a straight-chain or a branched-chain alkylene group having 1 to 6 carbon atoms and m represents an integer of 1 to 55, R4 represents —O— or —NH—, R5 represents a divalent aliphatic hydrocarbon group, a divalent alicyclic hydrocarbon group, or a divalent aromatic hydrocarbon group, and n represents an integer of 1 to 100,
- wherein the urethane pre-polymer (I) has 0.5 to 10% by mass of the NCO content measured according to JISK0113 using a potentiometric titration method, and the urethane pre-polymer (II) has 0.5 to 10% by mass of the NCO content measured according to JISK0113 using a potentiometric titration method, and
- wherein the content of the siloxane skeleton in the urethane pre-polymer (II) is 0.001 to 0.5% by mass relative to 100% by mass of the total amount of an overall NCO group-containing compound contained in the curable composition,
- wherein the foam is a closed cell foam, and
- wherein
- the cells have a mode average diameter <150 μm, or
- five or fewer cells per 4 mm2 have a cell diameter ≥250 μm.
A polyurethane foam produced from a curable composition comprising:
- an isocyanate group-containing urethane pre-polymer (I) that has an oxyalkylene ether skeleton and no siloxane skeleton;
- and
- an isocyanate group-containing urethane pre-polymer (II) that has a siloxane skeleton and an oxyalkylene ether skeleton, represented by the following formula (2),
- wherein each R1 is independently a monovalent hydrocarbon group, each R2 is independently a straight-chain or a branched-chain alkylene group having 1 to 6 carbon atoms, each R3 is independently an oxyalkylene group represented by a formula —[R6—O]m—, wherein R6 represents a straight-chain or a branched-chain alkylene group having 1 to 6 carbon atoms and m represents an integer of 1 to 55, R4 represents —O— or —NH—, R5 represents a divalent aliphatic hydrocarbon group, a divalent alicyclic hydrocarbon group, or a divalent aromatic hydrocarbon group, and n represents an integer of 1 to 100,
- wherein the urethane pre-polymer (I) has 0.5 to 10% by mass of the NCO content measured according to JISK0113 using a potentiometric titration method, and the urethane pre-polymer (II) has 0.5 to 10% by mass of the NCO content measured according to JISK0113 using a potentiometric titration method, and
- wherein the content of the siloxane skeleton in the urethane pre-polymer (II) is 0.001 to 0.5% by mass relative to 100% by mass of the total amount of an overall NCO group-containing compound contained in the curable composition,
- wherein
- the foam is flexible, or
- the curable composition has a volume and the polyurethane foam has a volume, expansion ratio of the polyurethane foam volume to curable composition volume ranges from 3:1 to 4:1.
A closed-cell polyurethane foam produced from mixing components consisting of:
- a gas selected from the group consisting of air, carbon dioxide, nitrogen, oxygen, argon, and krypton,
- a filler,
- a curing agent,
- a plasticizer, and
- a curable composition comprising:
- an isocyanate group-containing urethane pre-polymer (I) that has an oxyalkylene ether skeleton and no siloxane skeleton;
- and
- an isocyanate group-containing urethane pre-polymer (II) that has a siloxane skeleton and an oxyalkylene ether skeleton, represented by the following formula (2),
- wherein each R1 is a methyl group, each R2 is independently a propylene group, each R3 is independently an oxyalkylene group represented by a formula —[R6—O]m—, wherein R6 represents an ethylene group or a propylene group and m represents an integer of 1 to 55, R4 represents —O— or —NH—, R5 represents a divalent aliphatic hydrocarbon group, a divalent alicyclic hydrocarbon group, or a divalent aromatic hydrocarbon group, and n represents an integer of 1 to 100;
- wherein the closed cell foam cells have a mode average diameter of <150 μm;
- wherein five or fewer cells per 4 mm2 have a cell size ≥250 μm;
- wherein the foam is free of hydrofluorocarbons (HFCs) and/or chlorofluorocarbons (CFCs);
- and
- wherein the foam has water sealing properties.
Dependencies are inferred from the claim text.